Antonio Silvani Selected Research

Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))

1/2022

IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Silvani Research Topics

Disease

18	Neoplasms (Cancer) 01/2021 - 05/2003
15	Glioma (Gliomas) 02/2022 - 05/2003
15	Glioblastoma (Glioblastoma Multiforme) 05/2019 - 05/2003
3	Brain Neoplasms (Brain Tumor) 01/2022 - 04/2003
3	Disease Progression 05/2019 - 08/2009
3	Neoplasm Metastasis (Metastasis) 09/2009 - 06/2008
2	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 05/2003
2	Pituitary Neoplasms (Pituitary Adenoma) 09/2018 - 06/2008
2	Epilepsy (Aura) 01/2017 - 05/2016
2	Seizures (Absence Seizure) 09/2013 - 04/2008
2	Brain Diseases (Brain Disorder) 09/2013 - 09/2009
1	Meningioma (Meningiomas) 01/2022
1	Fatigue 01/2022
1	Ketosis 01/2021
1	Prolactinoma (Prolactinomas) 09/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Parkinsonian Disorders (Parkinsonism) 05/2016
1	Nervous System Diseases (Neurological Disorders) 01/2016
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2016
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 04/2015
1	Stroke (Strokes) 09/2013
1	Migraine Disorders (Migraine) 09/2013
1	Meningitis 01/2009
1	Breast Neoplasms (Breast Cancer) 06/2008
1	Thromboembolism 02/2006
1	Residual Neoplasm 04/2005
1	Germinoma 02/2005
1	Multiple Sclerosis 02/2004

Drug/Important Bio-Agent (IBA)

8	Temozolomide (Temodar)FDA LinkGeneric 09/2018 - 01/2004
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2012 - 05/2003
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 04/2008
3	Carmustine (FIVB)FDA Link 04/2013 - 08/2009
3	Mitoxantrone (Novantrone)FDA LinkGeneric 05/2008 - 04/2003
2	fotemustine (Muphoran)IBA 01/2019 - 04/2008
2	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2009 - 05/2004
2	Biological ProductsIBA 09/2009 - 07/2006
2	Plasminogen Activator Inhibitor 1IBA 02/2006 - 02/2004
2	Cisplatin (Platino)FDA LinkGeneric 02/2005 - 01/2004
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	TrabectedinIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	KetonesIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	IDN 5109 (BAY 59-8862)IBA 05/2019
1	Pharmaceutical PreparationsIBA 09/2018
1	Cabergoline FDA LinkGeneric 09/2018
1	Valproic Acid (Depakote)FDA LinkGeneric 05/2016
1	AntibodiesIBA 01/2016
1	Antimitotic AgentsIBA 12/2015
1	Conditioned Culture MediaIBA 12/2013
1	Biomarkers (Surrogate Marker)IBA 05/2012
1	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 11/2011
1	Bevacizumab (Avastin)FDA Link 11/2011
1	sagopiloneIBA 10/2009
1	Chemokine ReceptorsIBA 09/2009
1	Carcinoembryonic AntigenIBA 01/2009
1	Tumor Biomarkers (Tumor Markers)IBA 01/2009
1	EnzymesIBA 04/2008
1	Procarbazine (Matulane)FDA Link 04/2008
1	MethyltransferasesIBA 05/2007
1	DNA (Deoxyribonucleic Acid)IBA 05/2007
1	O-(6)-methylguanineIBA 05/2007
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 07/2006
1	ChemokinesIBA 07/2006
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 07/2006
1	CXCR ReceptorsIBA 07/2006
1	thiamine triphosphorate (TTP)IBA 07/2006
1	CoagulantsIBA 02/2006
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2005
1	Vinblastine (Vinblastine Sulfate)FDA Link 02/2005
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2004
1	fibrin fragment D (D-dimer)IBA 02/2004
1	Lipoprotein(a)IBA 02/2004
1	HomocysteineIBA 02/2004
1	Antineoplastic Agents (Antineoplastics)IBA 01/2004
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 01/2004
1	Interleukin-8 (Interleukin 8)IBA 05/2003
1	Interleukin-12 (IL 12)IBA 05/2003

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2018 - 02/2005
10	Radiotherapy 07/2017 - 02/2005
7	Therapeutics 01/2022 - 04/2008
3	Chemoradiotherapy 12/2015 - 11/2011
2	Aftercare (After-Treatment) 02/2022 - 11/2021
2	Re-Irradiation 08/2015 - 06/2015
1	Ketogenic Diet 01/2021
1	Combined Modality Therapy 09/2018
1	Transplantation 04/2015
1	Drug Tapering 08/2009
1	Radioimmunotherapy 04/2005
1	Immunotherapy 04/2005
1	Neoadjuvant Therapy 02/2005